1.4. Analysis.
Comparison 1: Ataluren versus placebo, Outcome 4: FEV1 % predicted ‐ mean relative change from baseline: subgroup analysis of participants receiving chronic inhaled tobramycin
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.